Clinical Trials Currently Recruiting Patients

Clinical Trials Currently Active, Not Recruiting (Study is ongoing with completed enrollment. Closed for new patients).

  • Study: HALO-301 PEGPH20 in combination with ABRAXANE® (nab-paclitaxel) and gemcitabine
  • Indication: Metastatic Pancreatic Cancer
  • Phase: Phase 3
  • More Information:

Clinical Trials Completed.

  • Study: HALO-101 PEGPH20 in combination with KEYTRUDA® (pembrolizumab)
  • Indication: Non-Small Cell Lung Cancer and Gastric Cancer
  • Phase: Phase 1
  • More Information:


You are now leaving Halozyme is not responsible for or endorses the content of the linked site.